GeoVax Labs Archives

S&P 500, Dow, Nasdaq Slide Amid Labor Market Woes and Government Shutdown Fears – Nov. 6, 2025 -( $DDOG $INTG $LLY $MODD $NOK $RIO $VIX Rise!)

by Vista Partners LLC November 6, 2025 1100Views 0Likes

Wall Street ended Thursday, November 6, 2025, sharply lower as surging volatility and renewed skepticism over tech valuations sent both large and small caps reeling. The Dow Jones Industrial Average finished down 0.84% at 46,912.30, the S&P 500 lost 1.1% to close…

S&P 500, Dow, Nasdaq & Russell Snap Back —Nov. 5, 2025 -( $AMZN $AVGO $CAT $INTC $LLY $MCD $META $MTWO $NOK $OPEN $SER $SOAR $TSLA Rise!)

by Vista Partners LLC November 5, 2025 886Views 0Likes

Wall Street ushered in Wednesday, November 5, 2025 with a refreshed dose of optimism—and just a dash of sophisticated exasperation—as major indices snapped back from recent turbulence driven by AI sector jitters and global macroeconomic suspense. The S&P 500 closed at 6,796.29,…

Stocks Retreat As Fear & Uncertainty Surge On Election Day, Nov. 4, 2025 – ( $AAPL $HTZ $LLY $MTSR $PAY $SANM $VIX $XMTR Rise!)

by Vista Partners LLC November 4, 2025 544Views 0Likes

In sum, today's market action reflected deepening caution across asset classes, with macro and policy uncertainties intersecting management commentary for a more sober market tone. Investors are closely watching congressional negotiations on Election Day to end the government shutdown and anticipate further…

Federal Initiatives Spur GeoVax’s American-Made Biotech Pipeline -( $GOVX $IBB $XBI )

by Vista Partners LLC October 31, 2025 662Views 0Likes

GeoVax Labs (NASDAQ: GOVX), a clinical-stage biotechnology company, has recently sharpened its focus on addressing urgent global health threats through advanced vaccine development and manufacturing strategies. Since October, the Atlanta-based firm has released a series of statements highlighting regulatory wins, key interim…

Market Mood Shifts On Monday: From Tesla’s Pause to GeoVax’s Surge and Silver’s Shine -( $BYND $GOVX $SPY $TSLA $TKMS $KER.PA $SIL $GLD )

by Vista Partners LLC October 20, 2025 466Views 0Likes

Wall Street’s radar has lit up Monday as a collection of standout corporate and commodity stories shaped the trading landscape, not to mention the shift in understanding with regard to the Whte House's ongoing negation with China and tariffs—from consumer brands clawing…

Game Changer for Immunocompromised? GeoVax Makes Case at World Vaccine Congress Europe 2025 -( $GOVX $IBB $XBI )

by Vista Partners LLC October 9, 2025 604Views 0Likes

GeoVax Labs (NASDAQ: GOVX) is advancing its multi-antigen COVID-19 vaccine, GEO-CM04S1, with fresh clinical data set to take center stage at the World Vaccine Congress Europe 2025, Europe's largest vaccine event, held October 13-16 at the RAI Amsterdam Convention Centre in…

U.S. Based GeoVax Labs Seeks To Challenge Bavarian Nordic’s Vaccine Monopoly Amid $3 Billion Buyout – ( $GOVX $BVNKF $IBB $XBI )

by John F. Heerdink, Jr. September 22, 2025 532Views 0Likes

GeoVax Labs, Inc. (NASDAQ: GOVX), an American clinical-stage biotechnology company, is advancing its Modified Vaccinia Ankara (MVA) vaccine platform, positioning itself as a key domestic alternative to Europe's Bavarian Nordic in addressing critical global health threats such as Mpox and smallpox. This…

Clinical Success Pushes GeoVax Into Spotlight as A Multi-Antigen Vaccine Leader – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. September 15, 2025 527Views 0Likes

GeoVax Labs (Nasdaq: GOVX), an Atlanta-based biotechnology firm, has garnered attention following the release of promising Phase 2 clinical data for its multi-antigen COVID-19 vaccine candidate, GEO-CM04S1, in patients with chronic lymphocytic leukemia (CLL). The findings, presented at the recent International Workshop…

U.S.-Based GeoVax Emerges as Key Monopoly Challenger Amid $2.99B Bavarian Nordic Takeover – ($GOVX $IBB $XBI)

by John F. Heerdink, Jr. July 31, 2025 507Views 0Likes

Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…

GeoVax Labs: Progress, Regulatory Wins, and Strong Analyst Outlook – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. July 23, 2025 456Views 0Likes

Q2 2025 Financial and Business Momentum GeoVax Labs (NASDAQ: GOVX) is set to deliver its second quarter 2025 results on Monday, July 28, promising insights into a period of robust growth and scientific achievement. Key EMA Regulatory Milestone A breakthrough for GeoVax…

GeoVax Labs

Your Guide To Staying Informed In The Markets